Nayax
NYAX
47.01
-2.04
-4.16%
Nayax
US · NYAX
#2826 by market cap
Listed 2021
47.01
-2.04
-4.16%
Periodic snapshot; not a real-time feed.
· 2026-11-20 18:15
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.80, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +27.52% YoY
Margins
- Gross margin
- 48.19%
- Operating margin
- 9.44%
- Net margin
- 8.87%
Key ratios & quality
- Enterprise valuei
- 1.80B
- Altman Z-Scorei
- 2.80
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 48.71M | 63.63M | 78.78M | 119.13M | 173.51M | 235.49M | 314.01M | 400.43M |
| Gross profit | 21.28M | 26.55M | 37.18M | 48.16M | 60.04M | 88.29M | 141.53M | 192.96M |
| Selling & admin expenses | 11.53M | 16.36M | 21.79M | 37.95M | 53.28M | 57.93M | 78.03M | 95.62M |
| Research & development | 4.79M | 7.33M | 9.30M | 19.04M | 22.13M | 21.93M | 25.37M | 29.96M |
| Operating profit | 1.34M | -3.09M | -2.22M | -21.94M | -32.24M | -10.83M | 4.38M | 37.79M |
| Pretax profit | -3.68M | -5.63M | -6.10M | -24.14M | -37.06M | -14.67M | -4.38M | 34.57M |
| Tax | -47.00K | -143.00K | -15.00K | 632.00K | 451.00K | 1.22M | 1.25M | -950.00K |
| Net profit | -3.63M | -5.49M | -6.08M | -24.77M | -37.51M | -15.89M | -5.63M | 35.52M |
| Basic EPS | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 1 |
| Diluted EPS | -0.11 | -0.16 | -0.25 | -0.82 | -1.14 | -0.48 | -0.16 | 0.96 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 95.59M | 104.28M | 119.45M | 106.86M | 122.59M | 128.04M |
| Gross profit | 46.17M | 51.37M | 55.53M | 52.27M | 57.45M | 63.46M |
| Selling & admin expenses | 31.22M | 30.01M | 6.85M | 36.32M | 48.94M | 41.39M |
| Research & development | 7.73M | 8.82M | 6.25M | 8.00M | 10.61M | 9.19M |
| Operating profit | 9.52M | 7.85M | 12.30M | 4.13M | -6.65M | 3.70M |
| Pretax profit | 11.99M | 4.57M | 10.61M | 727.00K | -8.45M | -492.00K |
| Tax | 333.00K | 1.03M | -2.56M | -553.00K | 1.67M | 584.00K |
| Net profit | 11.65M | 3.54M | 13.17M | 1.28M | -10.12M | -1.08M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.31 | 0.09 | 0.36 | 0.03 | -0.27 | -0.03 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 40.21M | 54.52M | 156.05M | 150.46M | 203.41M | 287.66M | 620.16M |
| Cash & ST investments | -- | 4.41M | 8.28M | 87.38M | 33.96M | 39.66M | 92.46M | 320.71M |
| Inventory | -- | 4.52M | 5.04M | 7.69M | 23.81M | 20.56M | 19.77M | 28.59M |
| Total assets | -- | 69.49M | 92.75M | 216.01M | 230.49M | 323.86M | 432.89M | 852.64M |
| Total current liabilities | -- | 45.22M | 62.25M | 70.19M | 110.21M | 203.78M | 219.48M | 274.42M |
| Short-term debt | -- | 13.72M | 18.57M | 7.51M | 15.07M | 50.72M | 32.22M | 6.69M |
| Long-term debt | -- | 1.09M | 11.43M | 7.06M | 8.51M | 327.00K | 18.61M | 324.53M |
| Total liabilities | -- | 53,817,000.00 | 80,252,000.00 | 84,330,000.00 | 125,853,000.00 | 226,269,000.00 | 267,648,000.00 | 621,623,000.00 |
| Total equity | -- | 15.67M | 12.50M | 131.68M | 104.64M | 97.59M | 165.25M | 231.02M |
| Retained earnings | -- | -11.03M | -13.43M | -28.70M | -56.55M | -65.59M | -63.31M | -19.64M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 439.20M | 439.03M | 620.16M | 634.68M | 682.68M | 803.93M |
| Cash & ST investments | 172.91M | 172.81M | 320.71M | 306.24M | 304.07M | 453.32M |
| Inventory | 23.18M | 24.01M | 28.59M | 28.55M | 30.09M | 31.90M |
| Total assets | 633.31M | 637.71M | 852.64M | 871.81M | 929.08M | 1.06B |
| Total current liabilities | 260.91M | 256.74M | 274.42M | 295.49M | 321.77M | 483.26M |
| Short-term debt | 6.05M | 5.84M | 6.69M | 6.62M | 6.68M | 196.47M |
| Long-term debt | 152.44M | 152.94M | 324.53M | 322.12M | 345.91M | 298.89M |
| Total liabilities | 431,821,000.00 | 429,591,000.00 | 621,623,000.00 | 636,432,000.00 | 683,703,000.00 | 801,838,000.00 |
| Total equity | 201.49M | 208.11M | 231.02M | 235.38M | 245.38M | 256.64M |
| Retained earnings | -39.65M | -33.19M | -19.64M | -15.96M | -11.95M | -10.22M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.84M | -1.44M | 6.49M | -12.81M | -27.55M | 8.80M | 42.90M | 40.29M |
| Depreciation & amortization | 2.95M | 4.82M | 5.91M | 7.20M | 9.03M | 12.51M | 21.37M | 25.49M |
| Free cash flow | -2.85M | -8.12M | -1.37M | -21.85M | -42.77M | -7.76M | 17.93M | 12.19M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | 17.48M | 0 | 0 | 132.56M | 0 | 0 | 62.69M | 0 |
| Ending cash balance | 10.00M | 4.41M | 8.20M | 87.33M | 33.88M | 38.39M | 83.13M | 319.54M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 12.95M | 10.46M | 15.59M | 3.58M | -1.26M | 18.08M |
| Depreciation & amortization | 6.01M | 6.83M | 6.92M | 7.18M | 7.57M | 9.06M |
| Free cash flow | 5.57M | 3.85M | 8.50M | -6.02M | -13.12M | 10.05M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | -- | 0 | 0 | -- | -- | -- |
| Ending cash balance | 172.27M | 167.29M | 319.54M | 304.75M | 302.83M | 452.07M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -35.85 | -46.06 | -34.35 | -31.75 | -15.71 | -4.28 | 17.93 |
| ROA %i | -- | -7.56 | -7.71 | -16.04 | -16.80 | -5.73 | -1.49 | 5.53 |
| ROIC %i | -- | -12.26 | -12.41 | -24.27 | -25.54 | -9.05 | -1.46 | 10.25 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -32.74 | -26.43 | -13.63 |
| EBIT margin %i | -5.26 | -7.12 | -5.90 | -19.09 | -20.59 | -5.12 | 0.74 | 11.78 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 5.71 | 3.05 |
| Current ratioi | -- | 0.89 | 0.88 | 2.22 | 1.37 | 1.00 | 1.31 | 2.26 |
| Quick ratioi | -- | 0.64 | 0.47 | 1.73 | 0.79 | 0.61 | 0.88 | 1.72 |
| Debt / assetsi | -- | 28.09 | 37.90 | 9.24 | 12.81 | 17.04 | 12.68 | 39.60 |
| LT debt / equityi | -- | 39.54 | 132.64 | 9.46 | 13.81 | 4.59 | 13.73 | 143.25 |
| Interest coveragei | -2.30 | -4.12 | -3.21 | -16.30 | -27.01 | -4.59 | 0.35 | 3.74 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 34.73 | 39.71 | 44.05 | 38.14 | 32.15 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 11.74 | 12.92 | 17.93 | 14.24 | 3.52 | 1.40 |
| ROA %i | 3.96 | 4.42 | 5.53 | 4.12 | 1.01 | 0.38 |
| ROIC %i | 5.64 | 7.72 | 10.25 | 8.19 | 3.79 | 2.55 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.17 | 9.27 | 11.78 | 10.45 | 5.90 | 5.00 |
| FCF / sales %i | 5.52 | 3.51 | 3.05 | 2.79 | -- | -- |
| Current ratioi | 1.68 | 1.71 | 2.26 | 2.15 | 2.12 | 1.66 |
| Quick ratioi | 1.21 | 1.17 | 1.72 | 1.62 | 1.48 | 1.27 |
| Debt / assetsi | 25.52 | 25.34 | 39.60 | 38.34 | 38.58 | 47.52 |
| LT debt / equityi | 77.22 | 74.84 | 143.25 | 139.20 | 143.35 | 119.44 |
| Interest coveragei | 5.09 | 4.31 | 3.74 | 2.68 | 1.39 | 1.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-11-20 18:15:12 · For reference only, not investment advice and not tailored to your situation.
Nayax discussion 0 comments